Literature DB >> 18669597

Selective inactivation of Socs3 in SF1 neurons improves glucose homeostasis without affecting body weight.

Ren Zhang1, Harveen Dhillon, Huali Yin, Akihiko Yoshimura, Bradford B Lowell, Eleftheria Maratos-Flier, Jeffrey S Flier.   

Abstract

Suppressor of cytokine signaling 3 (Socs3) has been identified as a mediator of central leptin resistance, but the identity of specific neurons in which Socs3 acts to suppress leptin signaling remains elusive. The ventromedial hypothalamus (VMH) was recently shown to be an important site for leptin action because deleting leptin receptor within VMH neurons causes obesity. To examine the role of VMH Socs3 in leptin resistance and energy homeostasis, we generated mice lacking Socs3 specifically in neurons positive for steroidogenic factor 1 (SF1), which is expressed abundantly in the VMH. These mice had increased phosphorylation of signal transducer and activator of transcription-3 in VMH neurons, suggesting improved leptin signaling, and consistently, food intake and weight-reducing effects of exogenous leptin were enhanced. Furthermore, on either chow or high-fat diets, these mice had reduced food intake. Unexpectedly, energy expenditure was reduced as well. Mice lacking Socs3 in SF1 neurons, despite no change in body weight, had improved glucose homeostasis and were partially protected from hyperglycemia and hyperinsulinemia induced by high-fat diets. These results suggest that Socs3 in SF1 neurons negatively regulates leptin signaling and plays important roles in mediating leptin sensitivity, glucose homeostasis, and energy expenditure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669597      PMCID: PMC2584592          DOI: 10.1210/en.2008-0805

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  45 in total

Review 1.  Towards a molecular understanding of adaptive thermogenesis.

Authors:  B B Lowell; B M Spiegelman
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  Editorial: leptin as a therapeutic agent--trials and tribulations.

Authors:  C S Mantzoros; J S Flier
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

3.  Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men.

Authors:  C J Hukshorn; W H Saris; M S Westerterp-Plantenga; A R Farid; F J Smith; L A Campfield
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

4.  Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.

Authors:  S B Heymsfield; A S Greenberg; K Fujioka; R M Dixon; R Kushner; T Hunt; J A Lubina; J Patane; B Self; P Hunt; M McCamish
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

5.  Disruption of the gene encoding SF-1 alters the distribution of hypothalamic neuronal phenotypes.

Authors:  T L Dellovade; M Young; E P Ross; R Henderson; K Caron; K Parker; S A Tobet
Journal:  J Comp Neurol       Date:  2000-08-07       Impact factor: 3.215

6.  Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity.

Authors:  K El-Haschimi; D D Pierroz; S M Hileman; C Bjørbaek; J S Flier
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

7.  PTP1B regulates leptin signal transduction in vivo.

Authors:  Janice M Zabolotny; Kendra K Bence-Hanulec; Alain Stricker-Krongrad; Fawaz Haj; Yongping Wang; Yasuhiko Minokoshi; Young-Bum Kim; Joel K Elmquist; Louis A Tartaglia; Barbara B Kahn; Benjamin G Neel
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

8.  Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B.

Authors:  Alan Cheng; Noriko Uetani; Paul D Simoncic; Vikas P Chaubey; Ailsa Lee-Loy; C Jane McGlade; Brian P Kennedy; Michel L Tremblay
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

9.  Development of a transgenic green fluorescent protein lineage marker for steroidogenic factor 1.

Authors:  Nancy R Stallings; Neil A Hanley; Gregor Majdic; Liping Zhao; Marit Bakke; Keith L Parker
Journal:  Mol Endocrinol       Date:  2002-10

10.  Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome.

Authors:  Nathan C Bingham; Kimberly K Anderson; Anne L Reuter; Nancy R Stallings; Keith L Parker
Journal:  Endocrinology       Date:  2008-02-07       Impact factor: 4.736

View more
  57 in total

1.  Steroidogenic factor 1 directs programs regulating diet-induced thermogenesis and leptin action in the ventral medial hypothalamic nucleus.

Authors:  Ki Woo Kim; Liping Zhao; Jose Donato; Daisuke Kohno; Yong Xu; Carol F Elias; Charlotte Lee; Keith L Parker; Joel K Elmquist
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-02       Impact factor: 11.205

2.  Essential and sex-specific effects of mGluR5 in ventromedial hypothalamus regulating estrogen signaling and glucose balance.

Authors:  Micaella P Fagan; Dominique Ameroso; Alice Meng; Anna Rock; Jamie Maguire; Maribel Rios
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

3.  A treasure trove of gene expression patterns.

Authors:  Clifford B Saper
Journal:  Nat Neurosci       Date:  2010-06       Impact factor: 24.884

Review 4.  Multiple hypothalamic circuits sense and regulate glucose levels.

Authors:  Mahesh Karnani; Denis Burdakov
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-03       Impact factor: 3.619

5.  Hypothalamic dysfunction of the thrombospondin receptor α2δ-1 underlies the overeating and obesity triggered by brain-derived neurotrophic factor deficiency.

Authors:  Joshua W Cordeira; Jennifer A Felsted; Sarah Teillon; Shabrine Daftary; Micaella Panessiti; Jena Wirth; Miguel Sena-Esteves; Maribel Rios
Journal:  J Neurosci       Date:  2014-01-08       Impact factor: 6.167

Review 6.  Sixteen years and counting: an update on leptin in energy balance.

Authors:  Laurent Gautron; Joel K Elmquist
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

7.  Alpha2delta-1 in SF1+ Neurons of the Ventromedial Hypothalamus Is an Essential Regulator of Glucose and Lipid Homeostasis.

Authors:  Jennifer A Felsted; Cheng-Hao Chien; Dongqing Wang; Micaella Panessiti; Dominique Ameroso; Andrew Greenberg; Guoping Feng; Dong Kong; Maribel Rios
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

Review 8.  COUP-TFII revisited: Its role in metabolic gene regulation.

Authors:  Usman M Ashraf; Edwin R Sanchez; Sivarajan Kumarasamy
Journal:  Steroids       Date:  2018-11-24       Impact factor: 2.668

9.  The Circadian Clock in the Ventromedial Hypothalamus Controls Cyclic Energy Expenditure.

Authors:  Ricardo Orozco-Solis; Lorena Aguilar-Arnal; Mari Murakami; Rita Peruquetti; Giorgio Ramadori; Roberto Coppari; Paolo Sassone-Corsi
Journal:  Cell Metab       Date:  2016-03-08       Impact factor: 27.287

10.  Neuronal Rap1 Regulates Energy Balance, Glucose Homeostasis, and Leptin Actions.

Authors:  Kentaro Kaneko; Pingwen Xu; Elizabeth L Cordonier; Siyu S Chen; Amy Ng; Yong Xu; Alexei Morozov; Makoto Fukuda
Journal:  Cell Rep       Date:  2016-09-13       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.